Titration package for neramexane and its use in the treatment of an inner ear disorder

Details for Australian Patent Application No. 2008298017 (hide)

Owner Merz Pharma GmbH & Co. KGaA

Inventors Althaus, Michael; Krueger, Hagen; Rosenberg, Tanja; Seiller, Erhard; Ellers-Lenz, Barbara

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008298017

PCT Pub. Number WO2009/033651

Priority 61/067,083 25.02.08 US; 61/067,026 25.02.08 US; 07253630.3 12.09.07 EP; 60/993,396 12.09.07 US; 61/066,931 25.02.08 US; 08004777.2 14.03.08 EP; 08004778.0 14.03.08 EP; 08004776.4 14.03.08 EP

Filing date 10 September 2008

Wipo publication date 19 March 2009

Acceptance publication date 1 March 2012

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61J 1/03 (2006.01) Containers specially adapted for medical or pharmaceutical purposes

A61J 7/00 (2006.01) Administering medicines orally

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61P 27/16 (2006.01) Drugs for disorders of the senses

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/033651 Priority application(s): WO2009/033651

1 March 2012 Application Accepted

  Published as AU-B-2008298017

28 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008298018-1-amino-alkylcyclohexane derivatives for the treatment of cochlear tinnitus

2008298016-1-amino-alkylcyclohexane derivatives for the treatment and prevention of hearing loss